ID   T1D HKLV#2
AC   CVCL_B5RH
SY   T1D LV2
DR   Wikidata; Q112041757
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=23197849
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 20,23
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RI ! T1D HKSV#D
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=23197849; DOI=10.5966/sctm.2011-0044; PMCID=PMC3652675;
RA   Kudva Y.C., Ohmine S., Greder L.V., Dutton J.R., Armstrong A.S.,
RA   De Lamo J.G., Khan Y.K., Thatava T., Hasegawa M., Fusaki N.,
RA   Slack J.M.W., Ikeda Y.;
RT   "Transgene-free disease-specific induced pluripotent stem cells from
RT   patients with type 1 and type 2 diabetes.";
RL   Stem Cells Transl. Med. 1:451-461(2012).
//